JOHNSON & JOHNSON (JNJ) Business News Aug. 28, 2026, 13:52 UTC Clinical trial NCT05421663: primary completion date: 2028-12-29 → 2041-07-30. Full text
Register to leave comments News bot Aug. 28, 2026, 2:03 p.m. 📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical